The resolution designates July of each year as Uterine Fibroid Awareness Month in New Jersey, aiming to enhance public awareness and understanding of uterine fibroids, a common type of noncancerous tumor affecting many women. It highlights that between 20% to 50% of women of reproductive age currently have fibroids, with up to 77% likely to develop them before menopause. Symptoms can significantly impact quality of life, leading to complications such as heavy menstrual bleeding, pain, and infertility. The resolution emphasizes the need for improved awareness, education, and research, particularly as many individuals remain undiagnosed and often wait years for treatment.

The resolution also calls for the Governor to issue an annual proclamation recognizing this month and encourages public officials and citizens to engage in activities that promote awareness and support for those affected by uterine fibroids. It underscores the disparities in diagnosis and treatment among different racial groups, particularly noting that people of color are more likely to develop fibroids and experience severe symptoms. By designating July as Uterine Fibroid Awareness Month, the resolution seeks to foster initiatives that will lead to better understanding, research, and treatment options for this prevalent health issue.